Overexpression	NN
of	IN
squamous	JJ
cell	NN
carcinoma	NN
antigen	NN
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
:	:
clinicopathological	JJ
correlations	NNS
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
progressive	JJ
disorder	NN
with	IN
a	DT
poor	JJ
prognosis	NN
.	.

Epithelial	JJ
instability	NN
is	VBZ
a	DT
crucial	JJ
step	NN
in	IN
the	DT
development	NN
and	CC
progression	NN
of	IN
the	DT
disease	NN
,	,
including	VBG
neoplastic	JJ
transformation	NN
.	.

Few	JJ
tissue	NN
markers	NNS
for	IN
epithelial	JJ
instability	NN
have	VBP
been	VBN
reported	VBN
in	IN
IPF	NN
.	.

Squamous	JJ
cell	NN
carcinoma	NN
antigen	NN
(	(
SCCA	NN
)	)
is	VBZ
a	DT
serine-protease	NN
inhibitor	NN
typically	RB
expressed	VBN
by	IN
dysplastic	JJ
and	CC
neoplastic	JJ
cells	NNS
of	IN
epithelial	JJ
origin	NN
,	,
more	RBR
often	RB
in	IN
squamous	JJ
cell	NN
tumours	NNS
.	.

At	IN
present	JJ
,	,
no	DT
information	NN
is	VBZ
available	JJ
on	IN
its	PRP$
expression	NN
in	IN
IPF	NN
.	.

METHODS	NNS
:	:
SCCA	NN
and	CC
transforming-growth-factor-beta	NN
(	(
TGFbeta	NN
)	)
expression	NN
in	IN
surgical	JJ
lung	NN
biopsies	NNS
from	IN
22	CD
patients	NNS
with	IN
IPF	NN
and	CC
20	CD
control	NN
cases	NNS
was	VBD
examined	VBN
.	.

An	DT
in	FW
vitro	FW
study	NN
using	VBG
A549	NN
pneumocytes	NNS
was	VBD
also	RB
conducted	VBN
to	TO
investigate	VB
the	DT
relationship	NN
between	IN
SCCA	NNP
and	CC
TGFbeta	NN
expression	NN
.	.

SCCA	NN
and	CC
TGFbeta	NN
epithelial	JJ
expression	NN
was	VBD
evaluated	VBN
by	IN
immunohistochemistry	NN
and	CC
reverse	VB
transcription-PCR	NN
(	(
RT-PCR	NN
)	)
.	.

SCCA	NN
values	NNS
were	VBD
correlated	VBN
with	IN
different	JJ
pathological	JJ
and	CC
clinical	JJ
parameters	NNS
.	.

Time	NNP
course	NN
analysis	NN
of	IN
TGFbeta	NN
expression	NN
in	IN
A549	NN
pneumocytes	NNS
incubated	VBN
with	IN
different	JJ
SCCA	NN
concentrations	NNS
was	VBD
assessed	VBN
by	IN
real	JJ
time	NN
RT-PCR	NN
.	.

RESULTS	NNS
:	:
SCCA	NN
was	VBD
expressed	VBN
in	IN
many	JJ
metaplastic	JJ
alveolar	JJ
epithelial	JJ
cells	NNS
in	IN
all	DT
IPF	NN
cases	NNS
with	IN
a	DT
mean	JJ
value	NN
of	IN
24.9	CD
%	NN
while	IN
it	PRP
was	VBD
seen	VBN
in	IN
only	RB
two	CD
control	NN
patients	NNS
in	IN
up	RB
to	TO
5	CD
%	NN
of	IN
metaplastic	JJ
cells	NNS
.	.

In	IN
patients	NNS
with	IN
IPF	NN
,	,
SCCA	NNP
correlated	VBD
positively	RB
with	IN
extension	NN
of	IN
fibroblastic	JJ
foci	NNS
(	(
r	NN
=	JJ
0.49	CD
,	,
p	NN
=	JJ
0.02	CD
)	)
,	,
expression	NN
of	IN
TGFbeta	NN
(	(
r	NN
=	JJ
0.78	CD
,	,
p	NN
<	JJR
0.0001	CD
)	)
and	CC
with	IN
carbon	NN
monoxide	NN
transfer	NN
factor	NN
decline	NN
after	IN
9	CD
months	NNS
of	IN
follow-up	NN
(	(
r	NN
=	JJ
0.59	CD
,	,
p	NN
=	JJ
0.01	CD
)	)
.	.

In	FW
vitro	FW
experiments	NNS
showed	VBD
that	IN
incubation	NN
of	IN
cultured	VBN
cells	NNS
with	IN
SCCA	NN
induced	VBD
TGFbeta	NN
expression	NN
,	,
with	IN
a	DT
peak	NN
at	IN
24	CD
h.	NN
CONCLUSION	NN
:	:
Our	PRP$
findings	NNS
provide	VBP
for	IN
the	DT
first	JJ
time	NN
a	DT
potential	JJ
mechanism	NN
by	IN
which	WDT
SCCA	NN
secreted	VBN
from	IN
metaplastic	JJ
epithelial	JJ
cells	NNS
may	MD
exert	VB
a	DT
profibrotic	JJ
effect	NN
in	IN
IPF	NN
.	.

SCCA	NNP
could	MD
be	VB
an	DT
important	JJ
biomarker	NN
in	IN
this	DT
incurable	JJ
disease	NN
.	.

